Javascript must be enabled to continue!
Abstract 4136605: Effect Of A Bone Morphogenetic Protein Receptor Type 2 Mutation On The Cardiomyocyte Response To Pressure Overload
View through CrossRef
Introduction:
A mutation in the Bone Morphogenetic Protein Receptor Type 2 (
BMPR2
) gene is in 70% of hereditary pulmonary arterial hypertension (hPAH) patients the causative mutation of the disease. Previous work demonstrated that right ventricular function is more impaired in hPAH patients with a BMPR2 mutation. However, the underlying mechanism remains elusive. Moreover, natriuretic peptides, such as N-terminal Brain Natriuretic Peptides (NTproBNP) and Mid Regional proAtrial Natriuretic Peptides (MRproANP), are secreted from cardiomyocytes upon stretch as adaptation to increased pressure overload. We hypothesize that the
BMPR2
mutation impairs the response to increased pressure overload. For this purpose, we make use of ventricular induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) of hPAH patients carrying a
BMPR2
mutation and their isogenic controls in which the mutation was corrected.
Aim:
To study the effect of a
BMPR2
mutation on the response to pressure overload
in vitro
.
Methods:
iPSCs from 2 hPAH patients and its isogenic controls were used. iPSCs were differentiated into ventricular iPSC-CMs and stretched 10% equiaxially for 24h at 1Hz on the Flexcell FX-6000 system. Natriuretic peptides gene expressions were quantified via RT-PCR. NTproBNP and MRproANP release were measured on cell supernatants throughout specific immunoassays. Normality of the data was checked, and statistics were performed accordingly.
Results:
No differences were observed on natriuretic peptides gene expression on static and stretched iPSC-CMs. There is a clear correlation between NTproBNP and MRproANP release (R
2
=0.83, p<0.0001, Figure 1A). Interestingly, hPAH iPSC-CMs showed higher baseline values for NTproBNP release compared to isogenic iPSC-CMs (p<0.01, Figure 1B). Furthermore, stretching resulted in increased NTproBNP and MRproANP secretion in both hPAH and isogenic iPSC-CMs (Figure 1B-C).
Conclusions:
Secretion of NTproBNP and MRproANP was closely correlated in iPSC-CMs. iPSC-CMs of hPAH patients with a
BMPR2
mutation showed higher baseline values of NTproBNP. Increased secretion of NTproBNP and MRproANP upon mechanical stimulation was similar between hPAH and isogenic iPSC-CMs. Experiments in atrial iPSC-CMs are currently ongoing to test potential differences in natriuretic peptide secretion between ventricular and atrial cardiomyocytes as the right atrium is also under stretch in PAH.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 4136605: Effect Of A Bone Morphogenetic Protein Receptor Type 2 Mutation On The Cardiomyocyte Response To Pressure Overload
Description:
Introduction:
A mutation in the Bone Morphogenetic Protein Receptor Type 2 (
BMPR2
) gene is in 70% of hereditary pulmonary arterial hypertension (hPAH) patients the causative mutation of the disease.
Previous work demonstrated that right ventricular function is more impaired in hPAH patients with a BMPR2 mutation.
However, the underlying mechanism remains elusive.
Moreover, natriuretic peptides, such as N-terminal Brain Natriuretic Peptides (NTproBNP) and Mid Regional proAtrial Natriuretic Peptides (MRproANP), are secreted from cardiomyocytes upon stretch as adaptation to increased pressure overload.
We hypothesize that the
BMPR2
mutation impairs the response to increased pressure overload.
For this purpose, we make use of ventricular induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) of hPAH patients carrying a
BMPR2
mutation and their isogenic controls in which the mutation was corrected.
Aim:
To study the effect of a
BMPR2
mutation on the response to pressure overload
in vitro
.
Methods:
iPSCs from 2 hPAH patients and its isogenic controls were used.
iPSCs were differentiated into ventricular iPSC-CMs and stretched 10% equiaxially for 24h at 1Hz on the Flexcell FX-6000 system.
Natriuretic peptides gene expressions were quantified via RT-PCR.
NTproBNP and MRproANP release were measured on cell supernatants throughout specific immunoassays.
Normality of the data was checked, and statistics were performed accordingly.
Results:
No differences were observed on natriuretic peptides gene expression on static and stretched iPSC-CMs.
There is a clear correlation between NTproBNP and MRproANP release (R
2
=0.
83, p<0.
0001, Figure 1A).
Interestingly, hPAH iPSC-CMs showed higher baseline values for NTproBNP release compared to isogenic iPSC-CMs (p<0.
01, Figure 1B).
Furthermore, stretching resulted in increased NTproBNP and MRproANP secretion in both hPAH and isogenic iPSC-CMs (Figure 1B-C).
Conclusions:
Secretion of NTproBNP and MRproANP was closely correlated in iPSC-CMs.
iPSC-CMs of hPAH patients with a
BMPR2
mutation showed higher baseline values of NTproBNP.
Increased secretion of NTproBNP and MRproANP upon mechanical stimulation was similar between hPAH and isogenic iPSC-CMs.
Experiments in atrial iPSC-CMs are currently ongoing to test potential differences in natriuretic peptide secretion between ventricular and atrial cardiomyocytes as the right atrium is also under stretch in PAH.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Poster 107: The Use of Coacervate Sustained Release System to Identify the Most Potent BMP for Bone Regeneration
Objectives:
Bone morphogenetic proteins (BMPs) belong to the transforming growth factor superfamily that were first discovered by Marshall Urist. There are 14 B...
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Defects in insulin-receptor function have been associated with insulin-resistant states such as obesity and non-insulin-dependent diabetes mellitus (NIDDM). Several types of mutati...
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
ABSTRACT
Background and Purpose
Pathological cardiomyocyte hypertrophy is a response to cardiac stress that typically leads to ...
GW24-e2217 AKAP150 anchored PKC to enhance cardiomyocyte damage in diabetes
GW24-e2217 AKAP150 anchored PKC to enhance cardiomyocyte damage in diabetes
Objectives
Cardiovascular disease is the main cause of death in patients with diabetes. It is reported that Protein kinase C signalling pathway plays a key role i...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Abstract P2029: The Role Of Runx1 In Cardiomyocyte Cell Cycle Activity And Its Impact On Cardiac Regeneration
Abstract P2029: The Role Of Runx1 In Cardiomyocyte Cell Cycle Activity And Its Impact On Cardiac Regeneration
Factors responsible for cardiomyocyte proliferation may serve as a potential therapeutic to stimulate endogenous myocardial regeneration following insult, such as ischemic injury. ...
CEBPA Gene Different Mutants Play Distinct Impacts On Tumor Suppressor Function Of C/EBP-Alpha and Bone Marrow Stromal Cells
CEBPA Gene Different Mutants Play Distinct Impacts On Tumor Suppressor Function Of C/EBP-Alpha and Bone Marrow Stromal Cells
Abstract
Introduction
CEBPA gene encodes CCAAT/enhancer-binding protein-alpha (C/EBPα), a crucial granulocytic differentiation f...

